{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-356869","form_type":"8-K","ticker":"ACAD","cik":"0001070494","company_name":"ACADIA PHARMACEUTICALS INC","filed_at":"2021-12-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.364721+00:00","generated_at":"2026-06-28T01:08:34.160228+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Acadia names Mark Schneyer permanent CFO; previously interim CFO since Sept 2021","bullets":["Mark Schneyer appointed EVP, CFO effective Dec 9, 2021; had served as interim CFO since Sept 2021.","Schneyer previously SVP, Business Development and CBO; joined Acadia from Pfizer in May 2020.","He led the Dec 2020 acquisition of CerSci Therapeutics, adding a Phase 2-ready pain program.","Schneyer retains responsibility for business development and investor relations; reports to CEO Steve Davis."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-356869","json":"https://secwatch.observer/filing/0001193125-21-356869.json","markdown":"https://secwatch.observer/filing/0001193125-21-356869.md","text":"https://secwatch.observer/filing/0001193125-21-356869.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1070494/000119312521356869/0001193125-21-356869-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1070494/000119312521356869/d246164d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T01:08:34.160228+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a3f349a525","claim":"Mark C. Schneyer was appointed as Executive Vice President, Chief Financial Officer at ACADIA PHARMACEUTICALS INC.","evidence_excerpt":"On December 9, 2021, the Board of Directors of Acadia Pharmaceuticals Inc. (the “Company”) appointed Mark C. Schneyer as Executive Vice President, Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1070494/000119312521356869/0001193125-21-356869-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President, Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}